360 related articles for article (PubMed ID: 33788185)
1. Galectin-3 Promotes ROS, Inflammation, and Vascular Fibrosis in Pulmonary Arterial Hypertension.
Barman SA; Bordan Z; Batori R; Haigh S; Fulton DJR
Adv Exp Med Biol; 2021; 1303():13-32. PubMed ID: 33788185
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension.
Fulton DJR; Li X; Bordan Z; Wang Y; Mahboubi K; Rudic RD; Haigh S; Chen F; Barman SA
Antioxid Redox Signal; 2019 Nov; 31(14):1053-1069. PubMed ID: 30767565
[No Abstract] [Full Text] [Related]
3. Galectin-3 is expressed in vascular smooth muscle cells and promotes pulmonary hypertension through changes in proliferation, apoptosis, and fibrosis.
Barman SA; Li X; Haigh S; Kondrikov D; Mahboubi K; Bordan Z; Stepp DW; Zhou J; Wang Y; Weintraub DS; Traber P; Snider W; Jonigk D; Sullivan J; Crislip GR; Butcher JT; Thompson J; Su Y; Chen F; Fulton DJR
Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L784-L797. PubMed ID: 30724100
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 mediates pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension.
Luo H; Liu B; Zhao L; He J; Li T; Zha L; Li X; Qi Q; Liu Y; Yu Z
J Am Soc Hypertens; 2017 Oct; 11(10):673-683.e3. PubMed ID: 28826890
[TBL] [Abstract][Full Text] [Related]
5. Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4.
He J; Li X; Luo H; Li T; Zhao L; Qi Q; Liu Y; Yu Z
J Am Soc Hypertens; 2017 May; 11(5):275-289.e2. PubMed ID: 28431936
[TBL] [Abstract][Full Text] [Related]
6. Adventitial Fibroblast Nox4 Expression and ROS Signaling in Pulmonary Arterial Hypertension.
Barman SA; Fulton D
Adv Exp Med Biol; 2017; 967():1-11. PubMed ID: 29047077
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
Kang Y; Zhang G; Huang EC; Huang J; Cai J; Cai L; Wang S; Keller BB
Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H853-H866. PubMed ID: 32108526
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 aggravates pulmonary arterial hypertension via immunomodulation in congenital heart disease.
Shen Q; Chen W; Liu J; Liang Q
Life Sci; 2019 Sep; 232():116546. PubMed ID: 31176777
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3- Mediated Transdifferentiation of Pulmonary Artery Endothelial Cells Contributes to Hypoxic Pulmonary Vascular Remodeling.
Zhang L; Li YM; Zeng XX; Wang XY; Chen SK; Gui LX; Lin MJ
Cell Physiol Biochem; 2018; 51(2):763-777. PubMed ID: 30463073
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension.
Fenster BE; Lasalvia L; Schroeder JD; Smyser J; Silveira LJ; Buckner JK; Brown KK
Heart Vessels; 2016 Jun; 31(6):939-46. PubMed ID: 25976729
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML
Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
13. Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
Sun XQ; Peters EL; Schalij I; Axelsen JB; Andersen S; Kurakula K; Gomez-Puerto MC; Szulcek R; Pan X; da Silva Goncalves Bos D; Schiepers REJ; Andersen A; Goumans MJ; Vonk Noordegraaf A; van der Laarse WJ; de Man FS; Bogaard HJ
Am J Respir Cell Mol Biol; 2021 Mar; 64(3):331-343. PubMed ID: 33264068
[TBL] [Abstract][Full Text] [Related]
14. Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling.
Wang S; Zeng H; Xie XJ; Tao YK; He X; Roman RJ; Aschner JL; Chen JX
Oncotarget; 2016 Sep; 7(37):58848-58861. PubMed ID: 27613846
[TBL] [Abstract][Full Text] [Related]
15. Eukaryotic elongation factor 2 kinase mediates monocrotaline-induced pulmonary arterial hypertension via reactive oxygen species-dependent vascular remodeling.
Kameshima S; Kazama K; Okada M; Yamawaki H
Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1298-305. PubMed ID: 25770246
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 inhibition ameliorates hypoxia-induced pulmonary artery hypertension.
Hao M; Li M; Li W
Mol Med Rep; 2017 Jan; 15(1):160-168. PubMed ID: 27959409
[TBL] [Abstract][Full Text] [Related]
17. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension.
Li T; Zha L; Luo H; Li S; Zhao L; He J; Li X; Qi Q; Liu Y; Yu Z
Aging Dis; 2019 Aug; 10(4):731-745. PubMed ID: 31440380
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.
Philip JL; Murphy TM; Schreier DA; Stevens S; Tabima DM; Albrecht M; Frump AL; Hacker TA; Lahm T; Chesler NC
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1167-H1177. PubMed ID: 30767670
[TBL] [Abstract][Full Text] [Related]
20. Visceral adipose tissue-derived serine protease inhibitor prevents the development of monocrotaline-induced pulmonary arterial hypertension in rats.
Sakamoto Y; Kameshima S; Kakuda C; Okamura Y; Kodama T; Okada M; Yamawaki H
Pflugers Arch; 2017 Nov; 469(11):1425-1432. PubMed ID: 28776262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
